We're very proud to announce that Suzy attended a roundtable hosted by the UK Government Chief Scientific Advisor Sir Patrick Vallance back in November. Suzy provided input relating to the goals for developing new monoclonal antibody therapies during a pandemic. Two of her papers were cited in the report and her contribution helped the government set evidence-based cost targets for this type of therapy.
Links
- Read the full 100 Days Mission Implementation Report here
- End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies. Biotechnology and Bioengineering, 118(9). Mahal, H., Branton, H. and Farid, S.S. (2021).
- Process economics evaluation of call-free synthesis for the commercial manufacture of antibody drug conjugates, Stamatis, C. and Farid, S.S. (2021).
Director's Summer Reading List 2025
Recommendations for your Summer reading from IGP's Director, Professor Henrietta L. Moore.
23 Jun 2025
Digital Transformation in ATMP Manufacturing held at UCL East on 16 May
The event convened over 60 invited stakeholders across industry, NHS, academia, and regulation to address key barriers in the scaling of CAR-T and other advanced therapy medicinal products (ATMPs).
20 Jun 2025
New hub to harness the power of microbes to turn waste into valuable products
UCL Biochemical Engineering is part of a pioneering new hub that is set to transform UK manufacturing by converting industrial waste into valuable, sustainable chemicals and materials.
19 Jun 2025
